| Absence of the TP53 Poly-A Signal Sequence Variant rs78378222 in Oral, Cervical and Breast Cancers in South India |
|
Rao, Arunagiri Kuha Deva Magendhra
(Department of Genetics, Dr. ALM PG Institute of Basic Medical Sciences, University of Madras)
Vinothkumar, Vilvanathan (Department of Genetics, Dr. ALM PG Institute of Basic Medical Sciences, University of Madras) Revathidevi, Sundaramoorthy (Department of Genetics, Dr. ALM PG Institute of Basic Medical Sciences, University of Madras) Arunkumar, Ganesan (Department of Genetics, Dr. ALM PG Institute of Basic Medical Sciences, University of Madras) Manikandan, Mayakannan (Department of Genetics, Dr. ALM PG Institute of Basic Medical Sciences, University of Madras) Arun, Kanagaraj (Department of Genetics, Dr. ALM PG Institute of Basic Medical Sciences, University of Madras) Rajkumar, Kottayasamy Seenivasagam (Centre for Oncology, Government Royapettah Hospital & Kilpauk Medical College) Ramani, Rajendran (Institute of Social Obstetrics and Government Kasturba Gandhi Hospital for Women and Children) Ramamurthy, Rajaraman (Centre for Oncology, Government Royapettah Hospital & Kilpauk Medical College) Munirajan, Arasambattu Kannan (Department of Genetics, Dr. ALM PG Institute of Basic Medical Sciences, University of Madras) |
| 1 | Egan KM, Nabors LB, Olson JJ, et al (2012). Rare TP53 genetic variant associated with glioma risk and outcome. J Med Genet, 49, 420-1. DOI |
| 2 | Enciso-Mora V, Hosking FJ, Di Stefano AL, et al (2013). Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222. Br J Cancer, 108, 2178-85. DOI |
| 3 | Guan X, Wang LE, Liu Z, et al (2013). Association between a rare novel TP53 variant (rs78378222) and melanoma, squamous cell carcinoma of head and neck and lung cancer susceptibility in non-Hispanic Whites. J Cell Mol Med, 17, 873-8. DOI |
| 4 | Li Y, Gordon MW, Xu-Monette ZY, et al (2013). Single nucleotide variation in the TP53 3' untranslated region in diffuse large B-cell lymphoma treated with rituximab-CHOP: a report from the International DLBCL Rituximab-CHOP Consortium Program. Blood, 121, 4529-40. DOI |
| 5 | Stacey SN, Sulem P, Jonasdottir A, et al (2011). A germline variant in the TP53 polyadenylation signal confers cancer susceptibility. Nat Genet, 43, 1098-103. DOI |
| 6 | Zhou L, Yuan Q, Yang M (2012). A functional germline variant in the P53 polyadenylation signal and risk of esophageal squamous cell carcinoma. Gene, 506, 295-7. DOI |
 |
Korea Institute of Science and Technology Information
Gwahangno, Yuseong-gu, Daejeon, 305-806, Korea TEL : +82-42-869-1752
Copyright (c) 2009 KISTI. All Rights Reserved. For more information mail to
webmaster
